12 × 6 Gy stereotactic radiotherapy for lung tumors. Is there a difference in response between lung metastases and primary bronchial carcinoma?

PURPOSE: The aim of this study was to evaluate the safety and long-term tumor control after stereotactic radiotherapy (SRT) with 12 × 6 Gy of patients with primary bronchial carcinoma (BC) or with pulmonary metastases (MET) of various solid tumors. Local progression-free survival (LPFS), progression...

Descripción completa

Detalles Bibliográficos
Autores principales: Lubgan, Dorota, Semrau, Sabine, Lambrecht, Ulrike, Gaipl, Udo S., Fietkau, Rainer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789716/
https://www.ncbi.nlm.nih.gov/pubmed/34255094
http://dx.doi.org/10.1007/s00066-021-01811-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789716/
https://www.ncbi.nlm.nih.gov/pubmed/34255094
http://dx.doi.org/10.1007/s00066-021-01811-3

Ejemplares similares